Header Logo

Connection

Sibongile Walaza to Influenza A Virus, H1N1 Subtype

This is a "connection" page, showing publications Sibongile Walaza has written about Influenza A Virus, H1N1 Subtype.
  1. Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza season. Euro Surveill. 2019 Nov; 24(45).
    View in: PubMed
    Score: 0,164
  2. Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa. Influenza Other Respir Viruses. 2019 01; 13(1):54-63.
    View in: PubMed
    Score: 0,153
  3. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
    View in: PubMed
    Score: 0,134
  4. Effectiveness and knowledge, attitudes and practices of seasonal influenza vaccine in primary healthcare settings in South Africa, 2010-2013. Influenza Other Respir Viruses. 2015 May; 9(3):143-50.
    View in: PubMed
    Score: 0,030
  5. Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting--South Africa, 1998-2009. Clin Infect Dis. 2014 May; 58(9):1241-9.
    View in: PubMed
    Score: 0,028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.